AVITA Medical (RCEL) Change in Accured Expenses (2019 - 2025)
AVITA Medical's (RCEL) quarterly Change in Accured Expenses came in at $1.0 million in Q4 2025, up 182.25% YoY from $367758.6 in Q4 2024, and up 28.78% on a QoQ basis from $806000.0 in Q3 2025.
AVITA Medical (RCEL) Change in Accured Expenses (2019 - 2025) Analysis & Trends
AVITA Medical (RCEL) has 7 years of Change in Accured Expenses data on file, last reported at $1.0 million in Q4 2025.
- Quarterly Change in Accured Expenses rose 182.25% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (up 306.86% YoY) and the FY2025 annual result came in at $2.7 million, up 306.86% from the prior year.
- Change in Accured Expenses climbed to $1.0 million in Q4 2025, from $806000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $3.0 million in Q2 2025 to a low of -$2.4 million in Q1 2022.
- A 5-year average of $127470.6 and a median of $16000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses jumped 1500.0% — and 2022, when it tumbled 17400.0%.
- Tracing RCEL's Change in Accured Expenses over 5 years: stood at $70000.0 in 2021, then soared by 3918.57% to $2.8 million in 2022, then slumped by 102.81% to -$79000.0 in 2023, then plunged by 1497.47% to -$1.3 million in 2024, then soared by 182.25% to $1.0 million in 2025.
- The last three Change in Accured Expenses figures came in at $1.0 million (Q4 2025), $806000.0 (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.80 Mn |
| 10 | AVITA Medical | 311.50 Mn | 300.36 Mn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 806,000.00 |
| Sep 30, 2025 | 806,000.00 |
| Jun 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Mar 31, 2025 | -2.11 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 283,000.00 |
| Sep 30, 2024 | 283,000.00 |
| Jun 30, 2024 | -239,000.00 |
| Jun 30, 2024 | -239,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Sep 30, 2023 | 566,000.00 |
| Sep 30, 2023 | 566,000.00 |